Article Details

AnaptysBio Presents Updated Data From Imsidolimab Phase 2 GALLOP Trial in ... - Yahoo Finance

Retrieved on: 2021-10-02 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

AnaptysBio Presents Updated Data From Imsidolimab Phase 2 GALLOP Trial in ... - Yahoo Finance. View article details on hiswai:

Excerpt

The oral presentation, titled “Imsidolimab, an Anti-IL-36 Receptor Monoclonal Antibody, in the Treatment of Generalized Pustular Psoriasis: Results from a ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up